The Dose Adjustment For Normal Eating (DAFNE) Trial: improvements in HbA1c still apparent and quality of life benefits well maintained at 4-year follow-up.

2007 - Speight J, Amiel S, Bradley C, Heller S, James P, Oliver L, Roberts S, Rogers H, Taylor C and Thompson G

Diabetic Medicine 24 (Suppl 1) 95, P224.